{
    "title": "University Technology Transfer Has Failed to Improve Access to Global Health Products during the COVID-19 Pandemic.",
    "doc_id": "35686821",
    "writer": "Herder M",
    "year": "2022",
    "summary": "Drawing upon the example of the lipid nanoparticle delivery technology - which was developed in and around the University of British Columbia in Vancouver, BC, and incorporated into the Pfizer/BioNTech COVID-19 vaccine - we show the divide between the university' â€¦",
    "abstract": "Publicly funded research has contributed enormously to many products that were developed in the face of the COVID-19 pandemic. Yet universities' technology transfer practices have failed to ensure that these products are available in low- and middle-income settings. Drawing upon the example of the lipid nanoparticle delivery technology - which was developed in and around the University of British Columbia in Vancouver, BC, and incorporated into the Pfizer/BioNTech COVID-19 vaccine - we show the divide between the university's stated principles to serve global health and technology transfer in practice. We outline three policy actions to realign universities' technology transfer practices in the service of global health.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/35686821/",
    "clean_text": "university technology transfer has failed to improve access to global health products during the covid pandemic drawing upon the example of the lipid nanoparticle delivery technology which was developed in and around the university of british columbia in vancouver bc and incorporated into the pfizer biontech covid vaccine we show the divide between the university publicly funded research has contributed enormously to many products that were developed in the face of the covid pandemic yet universities technology transfer practices have failed to ensure that these products are available in low and middle income settings drawing upon the example of the lipid nanoparticle delivery technology which was developed in and around the university of british columbia in vancouver bc and incorporated into the pfizer biontech covid vaccine we show the divide between the university s stated principles to serve global health and technology transfer in practice we outline three policy actions to realign universities technology transfer practices in the service of global health"
}